http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20070020445-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D453-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4035 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D453-02 |
| filingDate | 2005-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20070020445-A |
| titleOfInvention | Novel 2- (1-aza-bicyclo [2.2.2] oct-3-yl) -2,3-dihydroisoindol-1-one / 5,6-di for alpha 7 nicotinic acetylcholine receptor Hydro-furo [2,3-c] pyrrole-4-one derivative ligands |
| abstract | The present invention relates to nicotinic acetylcholine receptor-responsive compounds of formula (I), and stereoisomers, enantiomers, in vivo-hydrolysable precursors and pharmaceutically acceptable salts, pharmaceutical compositions and formulations containing them, alone or in treatment For use in combination with an active compound or substance to treat diseases and conditions, methods and intermediates used to prepare them, their use as medicaments, their use in the manufacture of medicaments, and for diagnostic and analytical purposes It relates to their use.n n n <Formula I>n n n n n n n n In the formula,n n n D represents O;n n n E represents CH 2 , NH, O or S;n n n n is 1 or 2.n n n Treatment or prevention of nicotinic acetylcholine receptor-responsive compounds, isoindoleone, neurological disorders, psychotic disorders or intellectual impairment disorders |
| priorityDate | 2004-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467310502 |
Total number of triples: 15.